Mark Holodniy

Professor of Medicine

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Public Health Public Health professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mark Holodniy is a Professor of Medicine at Stanford University, USA. His research focuses on COVID-19, including factors influencing mortality, vaccine effectiveness, and immunological outcomes. He also explores the relationship between neuropsychiatric diseases and regulatory variants, as well as the gut microbiome diversity in veteran populations. Recently, his work has included pivotal studies on mRNA vaccines against different variants of SARS-CoV-2 and the evaluation of self-collected blood specimens for antibody detection.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Matthew Pullen

University of Minnesota

UNITED STATES

View details

Timothy Hatlen

The Lundquist Institute

UNITED STATES

View details

David M Vock

University of Minnesota

UNITED STATES

View details

Fredrikke Christie Knudtzen

DENMARK

View details

Shijing Jia

University of Michigan

UNITED STATES

View details

Carlos A. Gomez

UNITED STATES

View details

Jarrod Mosier

University of Arizona

UNITED STATES

View details

Aneesh Mehta

Professor of Medicine

Emory University School of Medicine

UNITED STATES

View details

Dilek Ince

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Holodniy

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseases

Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans

Evaluation of independent self-collected blood specimens for COVID-19 antibody detection among the US veteran population

Association of Secretor Status and Recent Norovirus Infection With Gut Microbiome Diversity Metrics in a Veterans Affairs Population

Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Effectiveness of mRNA COVID-19 Booster Vaccines against Omicron and Delta Variants among US Veterans

Exposure Sources Among Veterans With Elevated Blood Lead Levels, United States, 2015-2021

Public health surveillance in the US Department of Veterans Affairs: evaluation of the Praedico surveillance system

Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016-2019

Implementation of large-scale laboratory-based detection of COVID-19 in the Veterans Health Administration, March 2020-February 2021

Collaborators (9)

Matthew Pullen

Timothy Hatlen

David M Vock

Fredrikke Christie Knudtzen

Shijing Jia

Carlos A. Gomez

Jarrod Mosier

Aneesh Mehta

Dilek Ince

Make your next move.